ONCOLife Issues
Featured Articles
Trending Articles
Radioligand Therapy Pluvicto Reduces Progression Risk by 28% in mHS Prostate Cancer
ONCOLife | 5 November 2025
Lenvatinib Plus Everolimus Improves Outcomes After PD-1 Failure in Kidney Cancer
ONCOLife | 6 November 2025
Novartis Invests $23 Billion to Boost Radioligand Manufacturing Capacity in Carlsbad
Pharma | 11 November 2025
Ribociclib Extends Disease-Free Survival Beyond Treatment in HR+/HER2– Early Breast Cancer
ONCOLife | 3 November 2025
DeLLphi-303: Tarlatamab Plus Chemo Achieves 71% Response in ES Small-Cell Lung Cancer
ONCOLife | 4 November 2025
Trodelvy Emerges as Potential New Standard for First-Line Metastatic TN Breast Cancer
ONCOLife | 24 October 2025
Datroway Extends Survival by 5 Months in Metastatic Triple-Negative Breast Cancer
ONCOLife | 21 October 2025
AI Analysis of Thymic Health Predicts Immunotherapy Success, Cutting Death Risk by 44%
ONCOLife | 18 October 2025
Lenvatinib Plus Pembrolizumab Delivers Durable 5-Year Survival in Endometrial Carcinoma
ONCOLife | 20 October 2025
Disarming Prostate Cancer: Dual Enzyme Blockade Weakens Tumors and Boosts Drug Response
ONCOLife | 14 October 2025
Reprogramming Cancer Cell Death: A New Immune-Based Strategy for Blood Cancers
ONCOLife | 12 October 2025
Datroway Improves Survival in First-Line Treatment of Metastatic Triple- Breast Cancer
ONCOLife
6 October 2025
FDA Approves Tecentriq–Zepzelca Combo as FL Maintenance Therapy for ES-SC Lung Cancer
FDA & EMA
3 October 2025
Dr. Eleni Lagkadinou Discusses How AbbVie Is Advancing Targeted Innovation for HT Cancers
ONCOLife
1 October 2025
FDA Approves Imlunestrant for ESR1-Mutated Metastatic Breast Cancer
FDA & EMA
27 September 2025
Giredestrant Plus Everolimus Improves PF Survival in ER+ Advanced Breast Cancer
ONCOLife
26 September 2025
The V Foundation and CVC Collaborate to Advance Breast Cancer Vaccine Research
ONCOLife
12 September 2025
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Clinical Trials
20 September 2025
Sugary Drinks Drive Colorectal Cancer Metastasis via SORD Pathway, Study Finds
ONCOLife
20 September 2025
FDA Grants Breakthrough Status to Raludotatug Deruxtecan for Refractory Ovarian Cancer
ONCOLife
17 September 2025
GSK to invest $30 billion in R&D and Manufacturing in the US over next 5 years
Pharma
18 September 2025
Climate-Driven Health Risks to Put $1.5 Trillion in Productivity at Stake by 2050
Opinion
18 September 2025
The Role of Third-Generation TKIs in Overcoming Chronic Myeloid Leukemia Resistance
ONCOLife
17 September 2025